Hormone replacement therapy: A time for pause

CMAJ. Canadian Medical Association Journal

Volumn 167, Issue 4, 2002, Pages 357-359

  Yusuf, Salim ^a   Anand, Sonia ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; CLONIDINE; CONJUGATED ESTROGEN PLUS MEDROXYPROGESTERONE ACETATE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ESTROGEN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PHYTOESTROGEN; PLACEBO; RALOXIFENE; SEROTONIN UPTAKE INHIBITOR; TAMOXIFEN; VITAMIN D;

AGING; BREAST CANCER; CANCER RISK; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL TRIAL; COLORECTAL CANCER; CONFIDENCE INTERVAL; DIET; DRUG EFFICACY; DRUG SAFETY; EXERCISE; GALLSTONE; HAZARD ASSESSMENT; HIP FRACTURE; HORMONE SUBSTITUTION; HOT FLUSH; HUMAN; HYSTERECTOMY; ISCHEMIC HEART DISEASE; LEG THROMBOSIS; LIFESTYLE; LOW FAT DIET; LUNG EMBOLISM; MENOPAUSE; META ANALYSIS; NOTE; OSTEOPOROSIS; PROPHYLAXIS; QUALITY OF LIFE; RISK BENEFIT ANALYSIS; SCORING SYSTEM; STROKE; TREATMENT OUTCOME; VEIN THROMBOSIS;

EID: 0036377805     PISSN: 08203946     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (25)

1. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. Principal results from the Women's Health Initiative randomized control trial
2. Menopause, local biologies, and cultures of aging
3. A critique of the grandmother hypotheses: Old and new
4. Oral estrogen replacement therapy versus placebo for hot flushes: A systematic review
5. Symptom relief and side effects of postmenopausal hormones: Results from the Postmenopausal Estrogen/Progestin Interventions Trial
6. Design of the Women's Health Initiative clinical trial and observational study
7. A prospective observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease
8. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women
9. Patient-specific decisions about hormone replacement therapy in postmenopausal women
10. The Coronary Drug Project: Findings leading to discontinuation of the 2.5-mg day estrogen group
11. The Coronary Drug Project: Initial findings leading to modifications of its research protocol
12. Impact of postmenopausal hormone therapy on cardiovascular events and cancer: Pooled data from clinical trials
13. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women
14. Effects of estrogen replacement on the progression of coronary artery atherosclerosis
15. A clinical trial of estrogen-replacement therapy after ischemic stroke
16. Tamoxifen for prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study
17. The effect of raloxifene on risk of breast cancer in postmenopausal women
18. Postmenopausal hormone therapy and cardiovascular disease
19. Breast cancer and hormone replacement therapy: Collaborative reanalysis of data from 51 epidemiological studies of 52 705 women with breast cancer and 108 411 women without breast cancer
20. Quality-of-life and depressive symptoms in postmenopausal women after receiving hormone therapy: Results from the Heart and Estrogen/Progestin Replacement Study (HERS) trial
21. Venlafaxine in management of hot flashes in survivors of breast cancer: A randomised controlled trial
22. Oral clonidine in post-menopausal patients with breast cancer experiencing tamoxifen induced hot flashes
23. Effect of soy phytoestrogens on hot flashes in postmenopausal women with breast cancer: A randomized, controlled clinical trial
24. A 60-year-old woman trying to discontinue hormone replacement therapy
25. Two decades of progress in preventing vascular disease